All News #Library
Biotech
iTeos Shares Interim Lung Study Results for Belrestotug
13 May 2025 //
GLOBENEWSWIRE
ITeos To Present Anti-TREM2 Antibody EOS-215 Data At AACR 2025
25 Mar 2025 //
GLOBENEWSWIRE
Iteos Announces 2025 Priorities And Anticipated Milestones
10 Jan 2025 //
GLOBENEWSWIRE
iTeos drops one of 3 clinical assets from pipeline
14 Dec 2024 //
FIERCE BIOTECH
iTeos Reports Interim Analysis Of Belrestotug + Dostarlimab In NSCLC
14 Sep 2024 //
GLOBENEWSWIRE
iTeos And GSK Initiate Phase 3 Study For Belrestotug And Dostarlimab In NSCLC
17 Jun 2024 //
GLOBENEWSWIRE
iTeos to raise $120M; Xbrane and STADA to out-license Lucentis biosimilar
10 May 2024 //
ENDPTS

Market Place
Sourcing Support